Tag Archives: could

AbbVie pegs growth to booming Skyrizi, Rinvoq in post-merger future. But neurology could be a ‘sleeper’

With its $ 63 billion merger with Allergan in the rearview, the new AbbVie is facing a major challenge as U.S. biosimilars for Humira cast a pall over the near-term future. But AbbVie figures its homegrown prospects will keep driving growth—and a couple of surprises from Allergan could make the forecast even rosier.  After six… Read More »

Doctors worry Trump could be ‘over-treated’ for coronavirus because he’s a VIP

White House physician Sean Conley (R) gives an update on the condition of US President Donald Trump, on October 3, 2020, at Walter Reed Medical Center in Bethesda, Maryland. Brendan Smialowski | AFP | Getty Images President Donald Trump‘s doctors are using almost every drug in the Covid-19 arsenal to treat him, worrying some physicians… Read More »

Pfizer coronavirus vaccine could be given to Americans before end of the year, CEO says

Albert Bourla, Pfizer Gian Ehrenzeller | Keystone | AP Pfizer‘s coronavirus vaccine could be distributed to Americans before the end of the year if found to be safe and effective, CEO Albert Bourla said Sunday.  The drugmaker should have key data from its late-stage trial for the Food and Drug Administration by the end of October, Bourla said… Read More »